Maternal and fetal adropin levels in gestational diabetes mellitus

Journal of Perinatal Medicine

Volumn 41, Issue 4, 2013, Pages 375-380

  Celik, Ebru ^a   Yilmaz, Ercan ^b   Celik, Onder ^b   Ulas, Mustafa ^c   Turkcuoglu, Ilgin ^b   Karaer, Abdullah ^b   Simsek, Yavuz ^b   Minareci, Yagmur ^d   Aydin, Suleyman ^c  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b INONU UNIVERSITY   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

^d Mediguven Hospital   (Turkey)

Author keywords

Adropin; Cord blood; Gestational diabetes mellitus; Glucose; Homeostasis model of assessment insulin resistance (HOMA IR)

Indexed keywords

ADROPIN; GLUCOSE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MATERNAL PLASMA; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ADULT; BIOLOGICAL MARKERS; BIRTH WEIGHT; BLOOD GLUCOSE; BLOOD PROTEINS; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; DIABETIC DIET; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INSULIN; INSULIN RESISTANCE; MALE; PREGNANCY;

EID: 84879800509     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/jpm-2012-0227     Document Type: Article

References (22)

1. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29(Suppl 1):43 - 8.
2. Butler AA, Tam CS, Stanhope KL, Wolfe BM, Ali MR, O'Keeffe M, et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab. 2012;97:3783- 91.
3. Farias M, San Martin R, Puebla C, Pearson JD, Casado JF, Pastor-Anglada M, et al. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. J Cell Physiol. 2006;208:451 - 60.
4. Ganesh Kumar K, Zhang J, Gao S, Rossi J, McGuinness OP, Halem HH, et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring). 2012;20:1394 - 402.
5. Guzman-Gutierrez E, Abarzua F, Belmar C, Nien JK, Ramirez MA, Arroyo P, et al. Functional link between adenosine and insulin: a hypothesis for fetoplacental vascular endothelial dysfunction in gestational diabetes. Curr Vasc Pharmacol. 2011;9:750 - 62.
6. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676 - 82.
7. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. J Am Med Assoc. 2005;294:2751 - 7.
8. King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care. 1998;21:B9 - B13.
9. Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008;8:468 - 81.
10. Leach L. Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease ? Microcirculation. 2011;18:263- 9.
11. Lian W, Gu X, Qin Y, Zheng X. Elevated plasma levels of adropin in heart failure patients. Intern Med. 2011;50:1523 - 7.
12. Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta M, et al. Adropin is a novel regulator of endothelial function. Circulation. 2010;122:185- 92.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412 - 9.
14. Naylor CD, Sermer M, Chen E, Farine D. Selective screening for gestational diabetes mellitus. N Engl J Med. 1997;337:1591 - 6.
15. Ozumba BC, Obi SN, Oli JM. Diabetes mellitus in pregnancy in an African population. Int J Gynaecol Obstet. 2004;84:114 - 9.
16. Pandolfi A, Di Pietro N. High glucose, nitric oxide, and adenosine: a vicious circle in chronic hyperglycaemia ? Cardiovasc Res. 2010;86:9 - 11.
17. Seshiah V, Balaji V, Balaji MS, Sanjeevi CB, Green A. Gestational diabetes mellitus in India. J Assoc Physicians India. 2004;52:707- 11.
18. Sobrevia L, Abarz ua F, Nien JK, Salomon C, Westermeier F, Puebla C, et al. Differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes. Placenta. 2011;32:159- 64.
19. Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. J Am Med Assoc. 1997;278:1078 - 83.
20. Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009;10:194 - 203.
21. Westermeier F, Salomon C, Gonzalez M, Puebla C, Guzman-Gutierrez E, Cifuentes F, et al. Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes. 2011; 60:1677 - 87.
22. Wolfe HM, Zador IE, Gross TL, Martier SS, Sokol RJ. The clinical utility of maternal body mass index in pregnancy. Am J Obstet Gynecol. 1991;164:1306 - 10.